Literature DB >> 106009

Antibody responses in the cerebrospinal fulid of cynomolgus monkeys after intracerebral inoculation with paramyxoviruses.

K Yamanouchi, T A Sato, F Kobune, A Shishido.   

Abstract

Cynomolgus monkeys with or without measles antibody were intracerebrally inoculated with measles or canine distemper viruses, and antibody responses in the cerebrospinal fluid (CSF) were investigated. In measles antibody-free monkeys, natural infection with wild measles virus or intracerebral inoculations with two attenuated measles vaccines evoked primary antibody responses to measles virus in the sera but not in the CSF. In measles-immune monkeys, intracerebral inoculation with the TYCSA strain of measles virus produced a significantly high titer of measles antibody in the CSF with a minimal rise in the serum antibody and resulted in a significant decrease in serum/CSF antibody ratios. Intracerebral inoculation of a neurotropic canine distemper virus, the Onderstepoort strain, into measles-immune monkeys caused production of both measles and distemper antibodies in the CSF. Inoculation of measles-immune monkeys intravenously with measles virus or intracerebrally with rubella virus, which has no antigenic relation to measles virus, failed to evoke a measles antibody response in the CSF. These results indicated that local production of measles antibody in the CSF was caused by a stimulus within the central nervous system of measles virus antigen or canine distemper virus antigen that partially cross-reacted with measles virus antigen as a secondary antibody response.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 106009      PMCID: PMC414146          DOI: 10.1128/iai.23.2.185-191.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Supraependymal cells of hypothalamic third ventricle: identification as resident phagocytes of the brain.

Authors:  R Bleier; R Albrecht; J A Cruce
Journal:  Science       Date:  1975-07-25       Impact factor: 47.728

2.  Viral antibodies in the CSF after acute CNS infections.

Authors:  R Cappel; L Thiry; G Clinet
Journal:  Arch Neurol       Date:  1975-09

3.  Viral antibody in the cerebrospinal fluid of patients with acute central nervous system infections.

Authors:  R Deibel; G D Schryver
Journal:  J Clin Microbiol       Date:  1976-04       Impact factor: 5.948

4.  Local antibody response to experimental poliovirus infection in the central nervous system of rhesus monkeys.

Authors:  P L Ogra; S S Ogra; S al-Nakeeb; P R Coppola
Journal:  Infect Immun       Date:  1973-12       Impact factor: 3.441

5.  Further studies on the immunologic relationships among measles, distemper, and rinderpest viruses.

Authors:  C Orvell; E Norrby
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

6.  Comparative immunofluorescent studies on measles, canine distemper, and rinderpest viruses. Immunofluorescence of measles, distemper, and rinderpest viruses.

Authors:  K Yamanouchi; F Kobune; A Fukuda; M Hayami; A Shishido
Journal:  Arch Gesamte Virusforsch       Date:  1970

7.  Ferritin-tagged antibody cross-reactions among rinderpest, canine distemper, and measles viruses.

Authors:  S S Breese; C J De Boer
Journal:  J Gen Virol       Date:  1973-07       Impact factor: 3.891

8.  Measles immunoglobulins in subacute sclerosing panencephalitis.

Authors:  J H Connolly; M Haire; D S Hadden
Journal:  Br Med J       Date:  1971-01-02

9.  Encephalomyelitis induced by canine distemper virus in non-human primates.

Authors:  K Yamanouchi; Y Yoshikawa; T A Sato; S Katow; F Kobune; K Kobune; N Uchida; A Shishido
Journal:  Jpn J Med Sci Biol       Date:  1977-10

10.  Antibody responses to antigenic determinants of influenza virus hemagglutinin. II. Original antigenic sin: a bone marrow-derived lymphocyte memory phenomenon modulated by thymus-derived lymphocytes.

Authors:  J L Virelizier; A C Allison; G C Schild
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.